vs
H2O AMERICA（HTO）与Bio-Techne（TECH）财务数据对比。点击上方公司名可切换其他公司
Bio-Techne的季度营收约是H2O AMERICA的1.6倍（$311.4M vs $199.4M），Bio-Techne净利率更高（16.4% vs 8.1%，领先8.3%），H2O AMERICA同比增速更快（1.5% vs -1.5%），过去两年H2O AMERICA的营收复合增速更高（15.3% vs 1.3%）
H2O Wireless是美国的预付费移动通信服务商，依托AT&T网络运营，隶属于MVNO（移动虚拟网络运营商）Locus通信，自2019年起Locus成为Telrite控股的子公司，此前2010年起曾是KDDI美国旗下资产。该品牌主打无限制套餐服务，支持用户自带或购买无锁智能手机入网，AT&T合约机/锁网机也可兼容使用。
Bio-Techne是美国头部生命科学企业，面向科研、诊断及生物工艺市场需求，研发、生产并销售生命科学试剂、仪器及配套服务，产品及解决方案广泛应用于基础研究、体外诊断、生物医药研发生产等场景，可为相关领域从业者提供可靠的专业工具支持。
HTO vs TECH — 直观对比
营收规模更大
TECH
是对方的1.6倍
$199.4M
营收增速更快
HTO
高出3.0%
-1.5%
净利率更高
TECH
高出8.3%
8.1%
两年增速更快
HTO
近两年复合增速
1.3%
损益表 — Q4 FY2025 vs Q3 FY2026
| 指标 | | |
|---|---|---|
| 营收 | $199.4M | $311.4M |
| 净利润 | $16.2M | $51.0M |
| 毛利率 | — | 66.9% |
| 营业利润率 | 16.6% | 24.2% |
| 净利率 | 8.1% | 16.4% |
| 营收同比 | 1.5% | -1.5% |
| 净利润同比 | -29.2% | 126.0% |
| 每股收益（稀释后） | $0.45 | $0.32 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收HTOTECH
| Q1 26 | — | $311.4M | ||
| Q4 25 | $199.4M | $295.9M | ||
| Q3 25 | $243.5M | — | ||
| Q2 25 | $197.8M | $317.0M | ||
| Q1 25 | $164.9M | $316.2M | ||
| Q4 24 | $196.5M | $297.0M | ||
| Q3 24 | $216.7M | $289.5M | ||
| Q2 24 | $173.1M | $306.1M |
净利润HTOTECH
| Q1 26 | — | $51.0M | ||
| Q4 25 | $16.2M | $38.0M | ||
| Q3 25 | $45.1M | — | ||
| Q2 25 | $24.7M | $-17.7M | ||
| Q1 25 | $16.6M | $22.6M | ||
| Q4 24 | $22.9M | $34.9M | ||
| Q3 24 | $38.7M | $33.6M | ||
| Q2 24 | $20.7M | $40.6M |
毛利率HTOTECH
| Q1 26 | — | 66.9% | ||
| Q4 25 | — | 64.6% | ||
| Q3 25 | — | — | ||
| Q2 25 | — | 62.7% | ||
| Q1 25 | — | 67.9% | ||
| Q4 24 | — | 65.3% | ||
| Q3 24 | — | 63.2% | ||
| Q2 24 | — | 66.4% |
营业利润率HTOTECH
| Q1 26 | — | 24.2% | ||
| Q4 25 | 16.6% | 18.4% | ||
| Q3 25 | 26.5% | — | ||
| Q2 25 | 22.2% | -7.5% | ||
| Q1 25 | 21.8% | 12.2% | ||
| Q4 24 | 22.2% | 16.0% | ||
| Q3 24 | 26.9% | 13.8% | ||
| Q2 24 | 23.4% | 15.0% |
净利率HTOTECH
| Q1 26 | — | 16.4% | ||
| Q4 25 | 8.1% | 12.8% | ||
| Q3 25 | 18.5% | — | ||
| Q2 25 | 12.5% | -5.6% | ||
| Q1 25 | 10.0% | 7.1% | ||
| Q4 24 | 11.7% | 11.7% | ||
| Q3 24 | 17.8% | 11.6% | ||
| Q2 24 | 12.0% | 13.3% |
每股收益（稀释后）HTOTECH
| Q1 26 | — | $0.32 | ||
| Q4 25 | $0.45 | $0.24 | ||
| Q3 25 | $1.27 | — | ||
| Q2 25 | $0.71 | $-0.11 | ||
| Q1 25 | $0.49 | $0.14 | ||
| Q4 24 | $0.70 | $0.22 | ||
| Q3 24 | $1.17 | $0.21 | ||
| Q2 24 | $0.64 | $0.26 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $20.7M | $209.8M |
| 总债务越低越好 | $1.9B | — |
| 股东权益账面价值 | $1.5B | $2.1B |
| 总资产 | $5.1B | $2.6B |
| 负债/权益比越低杠杆越低 | 1.23× | — |
8季度趋势，按日历期对齐
现金及短期投资HTOTECH
| Q1 26 | — | $209.8M | ||
| Q4 25 | $20.7M | $172.9M | ||
| Q3 25 | $11.3M | — | ||
| Q2 25 | $19.8M | $162.2M | ||
| Q1 25 | $23.7M | $140.7M | ||
| Q4 24 | $11.1M | $177.5M | ||
| Q3 24 | $4.0M | $187.5M | ||
| Q2 24 | $22.8M | $152.9M |
总债务HTOTECH
| Q1 26 | — | — | ||
| Q4 25 | $1.9B | $260.0M | ||
| Q3 25 | — | — | ||
| Q2 25 | — | $346.0M | ||
| Q1 25 | — | $330.0M | ||
| Q4 24 | $1.7B | $300.0M | ||
| Q3 24 | — | $300.0M | ||
| Q2 24 | — | $319.0M |
股东权益HTOTECH
| Q1 26 | — | $2.1B | ||
| Q4 25 | $1.5B | $2.0B | ||
| Q3 25 | $1.5B | — | ||
| Q2 25 | $1.5B | $1.9B | ||
| Q1 25 | $1.4B | $2.0B | ||
| Q4 24 | $1.4B | $2.1B | ||
| Q3 24 | $1.3B | $2.1B | ||
| Q2 24 | $1.3B | $2.1B |
总资产HTOTECH
| Q1 26 | — | $2.6B | ||
| Q4 25 | $5.1B | $2.5B | ||
| Q3 25 | $5.0B | — | ||
| Q2 25 | $4.8B | $2.6B | ||
| Q1 25 | $4.7B | $2.6B | ||
| Q4 24 | $4.7B | $2.7B | ||
| Q3 24 | $4.6B | $2.7B | ||
| Q2 24 | $4.4B | $2.7B |
负债/权益比HTOTECH
| Q1 26 | — | — | ||
| Q4 25 | 1.23× | 0.13× | ||
| Q3 25 | — | — | ||
| Q2 25 | — | 0.18× | ||
| Q1 25 | — | 0.16× | ||
| Q4 24 | 1.26× | 0.14× | ||
| Q3 24 | — | 0.14× | ||
| Q2 24 | — | 0.15× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $63.5M | — |
| 自由现金流经营现金流 - 资本支出 | — | — |
| 自由现金流率自由现金流/营收 | — | — |
| 资本支出强度资本支出/营收 | — | — |
| 现金转化率经营现金流/净利润 | 3.92× | — |
| 过去12个月自由现金流最近4个季度 | — | — |
8季度趋势，按日历期对齐
经营现金流HTOTECH
| Q1 26 | — | — | ||
| Q4 25 | $63.5M | — | ||
| Q3 25 | $77.3M | — | ||
| Q2 25 | $60.8M | $98.2M | ||
| Q1 25 | $43.2M | $41.1M | ||
| Q4 24 | $41.5M | $84.3M | ||
| Q3 24 | $53.5M | $63.9M | ||
| Q2 24 | $49.3M | $75.5M |
自由现金流HTOTECH
| Q1 26 | — | — | ||
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | $93.3M | ||
| Q1 25 | — | $31.0M | ||
| Q4 24 | — | $77.5M | ||
| Q3 24 | — | $54.7M | ||
| Q2 24 | — | $57.5M |
自由现金流率HTOTECH
| Q1 26 | — | — | ||
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | 29.4% | ||
| Q1 25 | — | 9.8% | ||
| Q4 24 | — | 26.1% | ||
| Q3 24 | — | 18.9% | ||
| Q2 24 | — | 18.8% |
资本支出强度HTOTECH
| Q1 26 | — | — | ||
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | 1.5% | ||
| Q1 25 | — | 3.2% | ||
| Q4 24 | — | 2.3% | ||
| Q3 24 | — | 3.2% | ||
| Q2 24 | — | 5.9% |
现金转化率HTOTECH
| Q1 26 | — | — | ||
| Q4 25 | 3.92× | — | ||
| Q3 25 | 1.71× | — | ||
| Q2 25 | 2.47× | — | ||
| Q1 25 | 2.61× | 1.82× | ||
| Q4 24 | 1.81× | 2.42× | ||
| Q3 24 | 1.39× | 1.90× | ||
| Q2 24 | 2.38× | 1.86× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
HTO
| Water Utility Services | $191.0M | 96% |
| Other | $8.4M | 4% |
TECH
| Protein Sciences segment revenue | $226.2M | 73% |
| Diagnostics and Spatial Biology segment revenue | $85.6M | 27% |
| Other revenue (1) | $5.4M | 2% |
